About iconjames5

Description

The Top Reasons For ADHD Medication Pregnancy's Biggest "Myths" About ADHD Medication Pregnancy Could Be True
ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There is a lack of information about how long-term exposure to these medications can affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological developmental disorders such as impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should consider the benefits of taking it versus the risks to the foetus. Doctors don't have the information needed to make unequivocal recommendations but they can provide information regarding the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not face an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a vast, population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy and those who had not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to ensure that the classification was accurate and to reduce any bias.

However, the researchers' study was not without its flaws. Researchers were unable in the beginning, to separate the effects of the medication from the disorder. This limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. In addition the study did not study the long-term outcomes of offspring.

The study found that babies whose mothers took ADHD medication during pregnancy had a higher chance of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers didn't take any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders and the higher risk of admission was not found to be influenced by which stimulant medications were taken during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an elevated risk of having a caesarean delivery or having a baby with an low Apgar score (less than 7). medications for adhd in adults did not appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the higher benefit for both mother and child from continued treatment for the woman's disorder. Physicians should talk to their patients about this issue and, if possible, help them improve coping skills which could reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to continue treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made without any evidence that is clear and definitive either way, so physicians must weigh their knowledge, the experiences of other doctors, and what research suggests on the subject, along with their own best judgment for each patient.

The issue of potential risks for infants can be extremely difficult. The research on this subject is based on observations instead of controlled studies and a lot of the results are conflicting. In addition, most studies limit their analysis to live births, which can underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these shortcomings by analyzing data on live and deceased births.

Conclusion A few studies have found an association between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show a neutral, or even slight negative impact. In each case an in-depth study of the benefits and risks is required.

For women suffering from ADHD who suffer from ADHD, the decision to stop taking medication is difficult if not impossible. In fact, in an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for patients with ADHD. Additionally, the loss of medication can interfere with the ability to complete work-related tasks and safely drive, which are important aspects of a normal life for many people suffering from ADHD.

She suggests women who are unsure about whether to continue or stop taking medication because of their pregnancy consider educating family members, friends, and coworkers on the condition, its impact on daily functioning, and on the advantages of continuing the current treatment regimen. In addition, educating them can aid in ensuring that the woman feels supported in her struggle with her decision. It is important to remember that certain drugs can be absorbed through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the drug can be transferred to the child.

Birth Defects Risk

As the use and misuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) is increasing, so does concern about the potential effects of these drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Utilizing two huge data sets researchers were able analyze more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the researchers found that exposure in the first trimester to ADHD medications was linked to an increased risk of specific heart defects, such as ventriculoseptal defect (VSD).

The authors of the study found no connection between early use of medication and other congenital anomalies, like facial clefting, or club foot. The findings are in line with previous studies showing an increase, but not significant, in the risk of heart malformations among women who started taking ADHD medications prior to the time of pregnancy. The risk was higher in the later part of pregnancy, when many women decide to stop taking their ADHD medications.

Women who used ADHD medications during the first trimester of their pregnancies were also more likely to experience caesarean sections, a low Apgar score after delivery and a baby that required help breathing at birth. The authors of the study were unable to eliminate selection bias because they limited the study to women with no other medical conditions that could have contributed to the findings.

Researchers hope that their research will inform physicians when they meet pregnant women. They advise that while a discussion of the benefits and risks is important but the decision to stop or keep treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is an option to think about, it isn't recommended due to the high prevalence of depression and other mental problems for women who are pregnant or who have recently given birth. Additionally, research suggests that women who stop taking their medication will have a harder time adjusting to a life without them after the baby is born.


Nursing

It can be a challenge to become a mom. Women who suffer from ADHD who have to deal with their symptoms while attending physician appointments and preparing for the arrival of their child and adapting to new routines in the home can experience severe challenges. Therefore, many women elect to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant drugs pass through breast milk in small quantities, so the risk for infant who is breastfeeding is low. However, the rate of exposure to medications by the infant can differ based on the dosage, frequency it is administered, and the time of the day the medication is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk. The impact of this on a newborn isn't well understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the absence of research. It is a difficult decision for the woman, who must weigh the benefits of taking her medication as well as the potential risks to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of ADHD and if they are planning or taking to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue to take their ADHD medication in a safe manner during pregnancy and while breast-feeding. In response, an increasing number of patients are choosing to do so. They have discovered, in consultation with their physicians, that the benefits of retaining their current medication far outweigh any possible risks.

Women with ADHD who are planning to nurse should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and strengthen strategies for coping. This should be a multidisciplinary process including obstetricians, GPs, and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both mother and child, as well as monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.

Feedback & Rating